← All diseases Brain and nervous system

Multiple sclerosis (progressive)

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchEvidence of the highest level only (104)Meta-analysis (24)Treatment guideline (1)Randomized trial (43)Systematic review (21)Phase 3 Study (15)Clinical trial (370)Review article (234)Early study (phase 1 or 2) (22)Case report (83)Laboratory or animal study (21)Commentary or editorial (19) Studies currently recruiting participants only (33)

Filter

Publications and studies (1542)

• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Dietary Supplements on Controlling Multiple Sclerosis Symptoms and Relapses: Current Clinical Evidence and Future Perspectives. (2019/09/12) ♡
• Recessive Charcot-Marie-Tooth and multiple sclerosis associated with a variant in MCM3AP. (2019/09/03) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Behind the wheel safety in palliative care: a literature review. (2019/09/01) ♡
• Multiple functional therapeutic effects of DL-3-n-butylphthalide in the cuprizone model of demyelination. (2019/09/01) ♡
• Analyzing social cognition and understanding of social inferences in patients with multiple sclerosis. A comparative study. (2019/09/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Glial and neuroaxonal biomarkers in a multiple sclerosis (MS) cohort. (2019/09/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Dietary Therapy in Secondary Progressive Multiple Sclerosis: A Case Report. (2019/08/07) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Ocular involvement in systemic sclerosis: A systematic literature review, it's not all scleroderma that meets the eye. (2019/08/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Life-threatening vitamin D intoxication due to intake of ultra-high doses in multiple sclerosis: A note of caution. (2019/08/01) ♡
• Prodrome in relapsing-remitting and primary progressive multiple sclerosis. (2019/07/01) ♡
• Effects of Constraint-Induced Movement Therapy on upper limb activity according to a bi-dimensional kinematic analysis in progressive multiple sclerosis patients: a randomized single-blind pilot study. (2019/07/01) ♡
• Lipid profile is associated with decreased fatigue in individuals with progressive multiple sclerosis following a diet-based intervention: Results from a pilot study. (2019/06/18) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Granulocyte-Macrophage Colony-Stimulating Factor as a Therapeutic Target in Multiple Sclerosis. (2019/06/01) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Treadmill training may be an effective form of task-specific training for improving mobility in people with Parkinson's disease and multiple sclerosis: a systematic review and meta-analysis. (2019/06/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Multiple Sclerosis Risk Factors and Pathogenesis. (2019/06/01) ♡
• Satiating Effect of a Ketogenic Diet and Its Impact on Muscle Improvement and Oxidation State in Multiple Sclerosis Patients. (2019/05/23) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Primary progressive multiple sclerosis to be treated with ocrelizumab: a mistaken case of cobalamin deficiency. (2019/05/14) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Lipoic Acid and Other Antioxidants as Therapies for Multiple Sclerosis. (2019/05/06) ♡
• Employment and Gainful Earnings Among Those With Multiple Sclerosis. (2019/05/01) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Prospective phase II clinical trial of autologous haematopoietic stem cell transplant for treatment refractory multiple sclerosis. (2019/05/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Relapsing remitting multiple sclerosis in progressive external ophthalmoplegia: A report of two cases. (2019/05/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Clinical commentary on 'Relapsing remitting multiple sclerosis in progressive external ophthalmoplegia: A report of two cases'. (2019/05/01) ♡
• Pediatric Multiple Sclerosis in Rio de Janeiro: Secondary Progression and Disability. (2019/05/01) ♡
• Cerebrospinal fluid NCAM levels are modulated by disease-modifying therapies. (2019/05/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Pathological cut-offs of global and regional brain volume loss in multiple sclerosis. (2019/04/01) ♡
• Safety and efficacy of autologous hematopoietic stem-cell transplantation following natalizumab discontinuation in aggressive multiple sclerosis. (2019/04/01) ♡
• Bojungikgi-tang Improves Muscle and Spinal Cord Function in an Amyotrophic Lateral Sclerosis Model. (2019/04/01) ♡
• High performance of cerebrospinal fluid immunoglobulin G analysis for diagnosis of multiple sclerosis. (2019/04/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Various strategies to improve efficacy of stem cell transplantation in multiple sclerosis: Focus on mesenchymal stem cells and neuroprotection. (2019/03/15) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Efficacy and safety of autologous hematopoietic stem-cell transplantation in multiple sclerosis: a systematic review and meta-analysis. (2019/03/01) ♡
• Cost-utility analysis of alemtuzumab in comparison with interferon beta, fingolimod, and natalizumab treatment for relapsing-remitting multiple sclerosis in Austria. (2019/03/01) ♡
• Expression of Bone Morphogenetic Proteins in Multiple Sclerosis Lesions. (2019/03/01) ♡
• The endocannabinoid 2-AG enhances spontaneous remyelination by targeting microglia. (2019/03/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. 'It's the unknown' - understanding anxiety: from the perspective of people with multiple sclerosis. (2019/03/01) ♡
• Progressive Onset Multiple Sclerosis: Demographic, Clinical and Laboratory Characteristics of Patients With and Without Relapses in the Course. (2019/03/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Vitamin D basis of Alzheimer's disease: from genetics to biomarkers. (2019/03/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Quantitative electroencephalography supports diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy. (2019/02/01) ♡
• Microglial modulation through colony-stimulating factor-1 receptor inhibition attenuates demyelination. (2019/02/01) ♡
• Structural network disruption markers explain disability in multiple sclerosis. (2019/02/01) ♡
• Structural and cognitive correlates of fatigue in progressive multiple sclerosis. (2019/02/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Siponimod for the treatment of secondary progressive multiple sclerosis. (2019/02/01) ♡
• Multiple sclerosis risk factors contribute to onset heterogeneity. (2019/02/01) ♡
• Patterns of care for Multiple Sclerosis in a setting of universal care access: A cross-sectional study. (2019/02/01) ♡
• Intravenous immunoglobulin (IVIG) in the vanguard therapy of Systemic Sclerosis. (2019/02/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Cerebrospinal fluid biomarkers link toxic astrogliosis and microglial activation to multiple sclerosis severity. (2019/02/01) ♡
• Acid sphingomyelinase: No potential as a biomarker for multiple sclerosis. (2019/02/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Severe disease activity in a patient with multiple sclerosis after daclizumab discontinuation. (2019/02/01) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Targeting microglia attenuates neuroinflammation-related neural damage in mice carrying human PLP1 mutations. (2019/02/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Ocrelizumab for the treatment of multiple sclerosis. (2019/02/01) ♡
• Multiple sclerosis with atypical MRI presentation: Results of a nationwide multicenter study in 57 consecutive cases. (2019/02/01) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.